Advertisement

Topics

Merlin Biosciences Limited Company Profile

16:27 EST 11th December 2018 | BioPortfolio

Merlin Biosciences Ltd is a specialised venture capital and advisory company dedicated to the life sciences sector. Merlin supports biotechnology companies in all stages of their development - from start-up, through pre-IPO and post flotation. Merlin has one of the largest, most experienced teams in Europe dedicated to investments in this sector and has a strategic collaboration with leading German life science advisory group BioConnect AG.

Location

12 St James' Square
London
London
SW1Y 4RB
United Kingdom

Contact

Phone: +44 20 7849 6003
Fax: +44 20 7976 1444
Email: bdamms@merlin-biosciences.com


News Articles [624 Associated News Articles listed on BioPortfolio]

Barrington Orthopedic Specialists Expands its Upper Extremity Practice

Barrington Orthopedic Specialists has added Dr. Gabriel Merlin, M.D. to its upper extremity practice. Upper extremity injuries represent approximately one-third of all emergency room visits according ...

Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion

Illumina, Inc. and Pacific Biosciences announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in an all-cash transaction....

Strategic partnership forms between Taconic Biosciences and Cyagen Biosciences

A strategic partnership has been formed between Taconic Biosciences and Cyagen Biosciences — both global companies that generate custom genetically engineered rodent models and associated services.

Illumina To Acquire Pacific Biosciences At $8.00/shr

SAN DIEGO (dpa-AFX) - Illumina, Inc. (ILMN) and Pacific Biosciences (PACB) announced an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in a...

Kuros Biosciences Ltd.: Kuros Biosciences appoints Strategic Advisory Board

Kuros Biosciences appoints Strategic Advisory Board Schlieren (Zurich), Switzerland, September 25, 2018 - Kuros Biosciences (SIX: KURN) today announced the formation of its Strategic Advisory Boar...

Kuros Biosciences Ltd.: Kuros Biosciences appoints Pascal Longlade as Chief Medical Officer

Kuros Biosciences appoints Pascal Longlade as Chief Medical Officer Schlieren (Zurich), Switzerland, August 23, 2018 Kuros Biosciences AG (SIX: KURN) announced today the appointment of Pascal Long...

FSD Pharma to acquire Therapix Biosciences

The transaction combines two highly-complementary businesses and creates a medical cannabis industry innovator focused on the research and development of advanced cannabinoid treatments. Therapix Bios...

Illumina to acquire Pacific Biosciences for $1.2bn

California-based Pacific Biosciences offers sequencing systems to help scientists resolve genetically complex problems The company’s technology is claimed to offer high accuracy, ultra-long read...

PubMed Articles [91 Associated PubMed Articles listed on BioPortfolio]

Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.

The neurofibromatosis type 2 (NF2) tumor suppressor protein Merlin functions as a negative regulator of cell growth and actin dynamics in different cell types amongst which Schwann cells have been ext...

The ERM family member Merlin is Required for Endometrial Gland Morphogenesis.

Disruption of endometrial gland formation or function can cause female infertility. Formation of endometrial glands via tubulogenesis of luminal epithelial cells requires the establishment and mainten...

Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.

Neurofibromatosis 2 (NF2) is a rare tumor suppressor syndrome that manifests with multiple schwannomas and meningiomas. There are no effective drug therapies for these benign tumors and conventional t...

Back cover.

Contents list.

Clinical Trials [16 Associated Clinical Trials listed on BioPortfolio]

Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for Episodic Treatment of Cold Sores

The purpose of this study is to determine if Merlin, a mixture of ethanol and glycolic acid, is safe and effective in the treatment of cold sores. Subjects who meet the requirements to pa...

Clinical Evaluation Of Remote Monitoring With Direct Alerts To Reduce Time From Event To Clinical Decision

St. Jude Medical developed the Merlin.net™ Patient Care Network (Merlin.net™ PCN) to augment or replace routine scheduled in-clinic visits. This investigation is designed with the hyp...

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Rheumatoid Arthritis

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment fo...

Health Economic Evaluation of Remote Follow up for Implantable Cardioverter Defibrillator (ICD) Patients

The purpose of the study is to define the economic value of implantable cardioverter defibrillator (ICD) remote monitoring for hospitals, third payers and patients in Italy. Aims of the st...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Companies [462 Associated Companies listed on BioPortfolio]

Merlin Biosciences Limited

Merlin Biosciences Ltd is a specialised venture capital and advisory company dedicated to the life sciences sector. Merlin supports biotechnology companies in all stages of their development - from st...

Merlin International

Merlin International is a leading provider of world-class technology solutions that enable commercial and government organizations to meet mission requirements and challenges. ...

Merlin BioMed Group

Merlin BioMed Group is a Registered Investment Advisor which invests globally in public and private healthcare companies, and is among the most successful healthcare asset management companies in the ...

Merlin, Marketpoint & TechTrans are divisions of Brynlake Ltd.

Merlin began life in 1981 specialising in new product development related work and in research for the pharmaceutical industry. It has since grown to provide a full range of research services and to ...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

More Information about "Merlin Biosciences Limited" on BioPortfolio

We have published hundreds of Merlin Biosciences Limited news stories on BioPortfolio along with dozens of Merlin Biosciences Limited Clinical Trials and PubMed Articles about Merlin Biosciences Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Merlin Biosciences Limited Companies in our database. You can also find out about relevant Merlin Biosciences Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record